Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Oderda

Showing results (131-140 of 175) with videos related to

Pageof 18
Sort By:
Urologic Oncology|May 29, 2026
ISUP 2 prostate cancer with suspicion of extraprostatic extension on MRI: Prostatectomy results and oncologic outcomesNorbert De Brek, Arthur Peyrottes, Romain Diamand, et al.
World Journal of Urology|August 11, 2020
Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemicRomain Diamand, Guillaume Ploussard, Mathieu Roumiguié, et al.
European Urology|June 24, 2022
Robotic Radical Prostatectomy for Prostate Cancer in Renal Transplant Recipients: Results from a Multicenter SeriesGiancarlo Marra, Marco Agnello, Andrea Giordano, et al.
Urologia Internationalis|January 4, 2011
Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian studyPaolo Gontero, Marco Oderda, Vincenzo Altieri, et al.
Urologic Oncology|October 12, 2020
Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassificationsRomain Diamand, Guillaume Ploussard, Mathieu Roumiguié, et al.
Prostate Cancer and Prostatic Diseases|April 29, 2025
Gleason pattern 4 and active surveillance in patients with grade group 2 prostate cancerAlessandro Uleri, Michael Baboudjian, Riccardo Leni, et al.
European Urology Oncology|February 18, 2025
Active Surveillance of Grade Group 2 Prostate Cancer: Oncological Outcomes from a Contemporary European CohortMichael Baboudjian, Riccardo Leni, Marco Oderda, et al.
European Urology|October 7, 2020
External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical ProstatectomyRomain Diamand, Guillaume Ploussard, Mathieu Roumiguié, et al.
World Journal of Urology|July 3, 2015
The morbidity of laparoscopic radical cystectomy: analysis of postoperative complications in a multicenter cohort by the European Association of Urology (EAU)-Section of Uro-TechnologySimone Albisinni, Marco Oderda, Laurent Fossion, et al.
The Journal of Urology|January 23, 2016
Critical Analysis of Early Recurrence after Laparoscopic Radical Cystectomy in a Large Cohort by the ESUTSimone Albisinni, Laurent Fossion, Marco Oderda, et al.
Pageof 18

Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
Urologic Oncology|May 29, 2026
ISUP 2 prostate cancer with suspicion of extraprostatic extension on MRI: Prostatectomy results and oncologic outcomesNorbert De Brek, Arthur Peyrottes, Romain Diamand, et al.
World Journal of Urology|August 11, 2020
Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemicRomain Diamand, Guillaume Ploussard, Mathieu Roumiguié, et al.
European Urology|June 24, 2022
Robotic Radical Prostatectomy for Prostate Cancer in Renal Transplant Recipients: Results from a Multicenter SeriesGiancarlo Marra, Marco Agnello, Andrea Giordano, et al.
Urologia Internationalis|January 4, 2011
Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian studyPaolo Gontero, Marco Oderda, Vincenzo Altieri, et al.
Urologic Oncology|October 12, 2020
Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassificationsRomain Diamand, Guillaume Ploussard, Mathieu Roumiguié, et al.
Prostate Cancer and Prostatic Diseases|April 29, 2025
Gleason pattern 4 and active surveillance in patients with grade group 2 prostate cancerAlessandro Uleri, Michael Baboudjian, Riccardo Leni, et al.
European Urology Oncology|February 18, 2025
Active Surveillance of Grade Group 2 Prostate Cancer: Oncological Outcomes from a Contemporary European CohortMichael Baboudjian, Riccardo Leni, Marco Oderda, et al.
European Urology|October 7, 2020
External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical ProstatectomyRomain Diamand, Guillaume Ploussard, Mathieu Roumiguié, et al.
World Journal of Urology|July 3, 2015
The morbidity of laparoscopic radical cystectomy: analysis of postoperative complications in a multicenter cohort by the European Association of Urology (EAU)-Section of Uro-TechnologySimone Albisinni, Marco Oderda, Laurent Fossion, et al.
The Journal of Urology|January 23, 2016
Critical Analysis of Early Recurrence after Laparoscopic Radical Cystectomy in a Large Cohort by the ESUTSimone Albisinni, Laurent Fossion, Marco Oderda, et al.
Pageof 18